
( (S 
    (NP-SBJ-1 
      (NP (NNS Earnings) )
      (PP (IN for) 
        (NP 
          (NP (JJS most) )
          (PP (IN of) 
            (NP 
              (NP (DT the) (NN nation) (POS 's) )
              (JJ major) (JJ pharmaceutical) (NNS makers) )))))
    (VP (VBP are) 
      (VP (VBN believed) 
        (S 
          (NP-SBJ (-NONE- *-1) )
          (VP (TO to) 
            (VP (VB have) 
              (VP (VBN moved) 
                (ADVP-DIR (RB ahead) )
                (ADVP-MNR (RB briskly) )
                (PP-TMP (IN in) 
                  (NP (DT the) (JJ third) (NN quarter) ))
                (, ,) 
                (SBAR-ADV (IN as) 
                  (S 
                    (NP-SBJ 
                      (NP (NNS companies) )
                      (PP (IN with) 
                        (NP (JJR newer) 
                          (, ,)
                          (JJ big-selling) (NN prescription) (NNS drugs) )))
                    (VP (VBD fared) 
                      (ADVP-MNR (RB especially) (RB well) ))))))))))
    (. .) ))
( (S 
    (PP (IN For) 
      (NP (DT the) (JJ third) (JJ consecutive) (NN quarter) ))
    (, ,) 
    (ADVP (RB however) )
    (, ,) 
    (NP-SBJ-1 
      (NP (JJS most) )
      (PP (IN of) 
        (NP 
          (NP (DT the) (NNS companies) (POS ') )
          (NNS revenues) )))
    (VP (VBD were) 
      (VP (VBN battered) 
        (NP (-NONE- *-1) )
        (PP (IN by) 
          (NP-LGS (JJ adverse) (NN foreign-currency) (NNS translations) ))
        (PP-PRP (IN as) 
          (NP 
            (NP (DT a) (NN result) )
            (PP (IN of) 
              (NP 
                (NP (DT the) (JJ strong) (NN dollar) )
                (ADVP-LOC (RB abroad) )))))))
    (. .) ))
( (S 
    (NP-SBJ (NNS Analysts) )
    (VP (VBD said) 
      (SBAR (IN that) 
        (S 
          (NP-SBJ 
            (NP (NNP Merck) (CC &) (NNP Co.) )
            (, ,) 
            (NP (NNP Eli) (NNP Lilly) (CC &) (NNP Co.) )
            (, ,) 
            (NP (NNP Warner-Lambert) (NNP Co.) )
            (CC and) 
            (NP 
              (NP (DT the) (NNP Squibb) (NNP Corp.) (NN unit) )
              (PP (IN of) 
                (NP (NNP Bristol-Myers) (NNP Squibb) (NNP Co.) ))))
          (DT all) 
          (VP (VBD benefited) 
            (PP-CLR (IN from) 
              (NP 
                (NP (JJ strong) (NNS sales) )
                (PP (IN of) 
                  (NP 
                    (NP 
                      (ADJP (RB relatively) (JJ new) )
                      (, ,) (JJ higher-priced) (NNS medicines) )
                    (SBAR 
                      (WHNP-1 (WDT that) )
                      (S 
                        (NP-SBJ (-NONE- *T*-1) )
                        (VP (VBP provide) 
                          (NP (JJ wide) (NN profit) (NNS margins) ))))))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 
      (NP 
        (ADJP (RBR Less) (JJ robust) )
        (NNS earnings) )
      (PP-LOC (IN at) 
        (NP 
          (NP (NNP Pfizer) (NNP Inc.) )
          (CC and) 
          (NP (NNP Upjohn) (NNP Co.) ))))
    (VP (VBD were) 
      (VP (VBN attributed) 
        (NP (-NONE- *-1) )
        (PP-CLR (TO to) 
          (NP 
            (NP 
              (NP (DT those) (NNS companies) (POS ') )
              (JJR older) (NNS products) )
            (, ,) 
            (SBAR 
              (WHNP-2 
                (NP (JJ many) )
                (WHPP (IN of) 
                  (WHNP (WDT which) )))
              (S 
                (NP-SBJ (-NONE- *T*-2) )
                (VP (VBP face) 
                  (NP 
                    (NP (JJ stiffening) (NN competition) )
                    (PP (IN from) 
                      (NP 
                        (NP (JJ generic) (NNS drugs) )
                        (CC and) 
                        (NP (JJ other) (NNS medicines) )))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Joseph) (NNP Riccardo) )
      (, ,) 
      (NP 
        (NP (DT an) (NN analyst) )
        (PP (IN with) 
          (NP (NNP Bear) 
            (, ,)
            (NNP Stearns) (CC &) (NNP Co.) )))
      (, ,) )
    (VP (VBD said) 
      (SBAR (IN that) 
        (S 
          (PP-TMP (IN over) 
            (NP (DT the) (JJ past) (JJ few) (NNS years) ))
          (NP-SBJ-1 (JJS most) (NN drug) (NNS makers) )
          (VP (VBP have) 
            (VP 
              (VP (VBN shed) 
                (NP (PRP$ their) (JJ slow-growing) (NNS businesses) ))
              (CC and) 
              (VP (VBN instituted) 
                (NP 
                  (NP (JJ other) (NN cost) (NNS savings) )
                  (, ,) 
                  (PP (JJ such) (IN as) 
                    (S-NOM 
                      (NP-SBJ (-NONE- *-1) )
                      (VP (VBG consolidating) 
                        (NP 
                          (NP (NN manufacturing) (NNS plants) )
                          (CC and) 
                          (NP (JJ administrative) (NNS staffs) ))))))))))))
    (. .) ))
( (S 
    (S-TPC-1 
      (PP-PRP (IN As) 
        (NP (DT a) (NN result) ))
      (, ,) (`` ``) 
      (NP-SBJ (JJ major) (JJ new) (NNS products) )
      (VP (VBP are) 
        (VP (VBG having) 
          (NP (JJ significant) (NN impact) )
          (, ,) 
          (PP-CLR 
            (ADVP (RB even) )
            (IN on) 
            (NP 
              (NP (DT a) (NN company) )
              (PP (IN with) 
                (NP 
                  (ADJP (RB very) (JJ large) )
                  (NNS revenues) )))))))
    (, ,) ('' '') 
    (NP-SBJ (NNP Mr.) (NNP Riccardo) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
( (S 
    (NP-SBJ (NNS Analysts) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ-1 
            (NP (NN profit) )
            (PP (IN for) 
              (NP 
                (NP (DT the) 
                  (QP (NN dozen) (CC or) (RB so) )
                  (JJ big) (NN drug) (NNS makers) )
                (, ,) 
                (PP (IN as) 
                  (NP (DT a) (NN group) ))
                (, ,) )))
          (VP (VBZ is) 
            (VP (VBN estimated) 
              (S 
                (NP-SBJ (-NONE- *-1) )
                (VP (TO to) 
                  (VP (VB have) 
                    (VP (VBN climbed) 
                      (NP-EXT 
                        (QP (IN between) (CD 11) (NN %) 
                          (CC and)
                          (CD 14) (NN %) )
                        (-NONE- *U*) ))))))))))
    (. .) ))
( (S 
    (SBAR-ADV (IN While) 
      (S 
        (NP-SBJ (DT that) )
        (VP (VBZ 's) (RB not) 
          (ADJP-PRD (JJ spectacular) ))))
    (, ,) 
    (NP-SBJ 
      (NP (NNP Neil) (NNP Sweig) )
      (, ,) 
      (NP 
        (NP (DT an) (NN analyst) )
        (PP (IN with) 
          (NP (NNP Prudential) (NNP Bache) )))
      (, ,) )
    (VP (VBD said) 
      (SBAR (IN that) 
        (S 
          (NP-SBJ 
            (NP (DT the) (NN rate) )
            (PP (IN of) 
              (NP (NN growth) )))
          (VP (MD will) (`` ``) 
            (VP (VB look) 
              (ADJP-PRD (RB especially) (JJ good) 
                (SBAR (IN as) 
                  (S 
                    (NP-SBJ-1 (-NONE- *) )
                    (VP (VBN compared) 
                      (NP (-NONE- *-1) )
                      (PP-CLR (TO to) 
                        (NP (JJ other) (NNS companies) ))))))
              (SBAR-ADV (IN if) 
                (S 
                  (NP-SBJ (DT the) (NN economy) )
                  (VP (VBZ turns) 
                    (ADVP-DIR (RB downward) )))))))))
    (. .) ('' '') ))
( (S 
    (NP-SBJ (NNP Mr.) (NNP Sweig) )
    (VP (VBD estimated) 
      (SBAR (IN that) 
        (S 
          (NP-SBJ-1 
            (NP 
              (NP (NNP Merck) (POS 's) )
              (NN profit) )
            (PP (IN for) 
              (NP (DT the) (NN quarter) )))
          (VP (VBD rose) 
            (PP-EXT (IN by) 
              (NP 
                (QP (RB about) (CD 22) )
                (NN %) ))
            (, ,) 
            (S-ADV 
              (NP-SBJ-2 (-NONE- *-1) )
              (VP (VBN propelled) 
                (NP (-NONE- *-2) )
                (PP (IN by) 
                  (NP-LGS 
                    (NP (NNS sales) )
                    (PP (IN of) 
                      (NP 
                        (NP (PRP$ its) (NN line-up) )
                        (PP (IN of) 
                          (NP 
                            (NP (JJ fast-growing) (NN prescription) (NNS drugs) )
                            (, ,) 
                            (PP (VBG including) 
                              (NP 
                                (NP 
                                  (NP (PRP$ its) (JJ anti-cholesterol) (NN drug) )
                                  (, ,) 
                                  (NP (NNP Mevacor) ))
                                (: ;) 
                                (NP 
                                  (NP (DT a) (JJ high) (NN blood) (NN pressure) (NN medicine) )
                                  (, ,) 
                                  (NP (NNP Vasotec) ))
                                (: ;) 
                                (NP 
                                  (NP (NNP Primaxin) )
                                  (, ,) 
                                  (NP (DT an) (NN antibiotic) ))
                                (, ,) 
                                (CC and)
                                (NP 
                                  (NP (NNP Pepcid) )
                                  (, ,) 
                                  (NP (DT an) (JJ anti-ulcer) (NN medication) ))))))))))))))))
    (. .) ))
( (S 
    (S-TPC-2 
      (NP-SBJ (NN Profit) )
      (VP (VBD climbed) 
        (SBAR-ADV (RB even) (IN though) 
          (S 
            (NP-SBJ-1 
              (NP (NNP Merck) (POS 's) )
              (NNS sales) )
            (VP (VBD were) 
              (VP (VBN reduced) 
                (NP (-NONE- *-1) )
                (PP-EXT (IN by) (`` ``) 
                  (NP 
                    (QP (CD one) (TO to) (CD three) )
                    (NN percentage) (NNS points) )
                  ('' '') )
                (PP-PRP (IN as) 
                  (NP 
                    (NP (DT a) (NN result) )
                    (PP (IN of) 
                      (NP (DT the) (JJ strong) (NN dollar) ))))))))))
    (, ,) 
    (NP-SBJ (NNP Mr.) (NNP Sweig) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S 
    (PP-TMP (IN In) 
      (NP 
        (NP (DT the) (JJ third) (NN quarter) )
        (PP (IN of) 
          (NP (CD 1988) ))))
    (, ,) 
    (NP-SBJ (NNP Merck) )
    (VP (VBD earned) 
      (NP 
        (NP 
          (QP ($ $) (CD 311.8) (CD million) )
          (-NONE- *U*) )
        (, ,) (CC or) 
        (NP 
          (NP (CD 79) (NNS cents) )
          (NP-ADV (DT a) (NN share) ))))
    (. .) ))
( (S 
    (PP-LOC (IN In) 
      (NP 
        (NP (NNP Rahway) )
        (, ,) 
        (NP (NNP N.J.) )
        (, ,) ))
    (NP-SBJ (DT a) (NNP Merck) (NN spokesman) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (DT the) (NN company) )
          (VP (VBZ does) (RB n't) 
            (VP (VB make) 
              (NP (NN earnings) (NNS projections) ))))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Mr.) (NNP Sweig) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (PRP he) )
          (VP (VBD estimated) 
            (SBAR (IN that) 
              (S 
                (NP-SBJ 
                  (NP 
                    (NP (NNP Lilly) (POS 's) )
                    (NNS earnings) )
                  (PP (IN for) 
                    (NP (DT the) (NN quarter) )))
                (VP (VBD jumped) 
                  (NP-EXT (RB about) (CD 20) (NN %) )
                  (, ,) 
                  (PP-PRP 
                    (ADVP (RB largely) )
                    (IN because) (IN of) 
                    (NP 
                      (NP (DT the) (NN performance) )
                      (PP (IN of) 
                        (NP (PRP$ its) (JJ new) (NN anti-depressant) (NNP Prozac) )))))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 
      (NP (DT The) (NN drug) )
      (, ,) 
      (VP (VBD introduced) 
        (NP (-NONE- *) )
        (NP-TMP (JJ last) (NN year) ))
      (, ,) )
    (VP (VBZ is) 
      (VP (VBN expected) 
        (S 
          (NP-SBJ (-NONE- *-1) )
          (VP (TO to) 
            (VP (VB generate) 
              (NP 
                (NP (NNS sales) )
                (PP (IN of) 
                  (NP 
                    (QP (RB about) ($ $) (CD 300) (CD million) )
                    (-NONE- *U*) )))
              (NP-TMP (DT this) (NN year) ))))))
    (. .) ))
( (S (`` ``) 
    (S-TPC-1 
      (NP-SBJ-2 (PRP It) )
      (VP (VBZ 's) 
        (VP (VBG turning) 
          (PRT (RP out) )
          (S 
            (NP-SBJ (-NONE- *-2) )
            (VP (TO to) 
              (VP (VB be) 
                (NP-PRD (DT a) (JJ real) (NN blockbuster) )))))))
    (, ,) ('' '') 
    (NP-SBJ (NNP Mr.) (NNP Sweig) )
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (. .) ))
( (S 
    (PP-TMP (IN In) 
      (NP 
        (NP (JJ last) (NN year) (POS 's) )
        (JJ third) (NN quarter) ))
    (, ,) 
    (NP-SBJ (NNP Lilly) )
    (VP (VBD earned) 
      (NP 
        (NP 
          (QP ($ $) (CD 171.4) (CD million) )
          (-NONE- *U*) )
        (, ,) (CC or) 
        (NP 
          (NP ($ $) (CD 1.20) (-NONE- *U*) )
          (NP-ADV (DT a) (NN share) ))))
    (. .) ))
( (S 
    (PP-LOC (IN In) 
      (NP (NNP Indianapolis) ))
    (, ,) 
    (NP-SBJ (NNP Lilly) )
    (VP (VBD declined) 
      (NP (NN comment) ))
    (. .) ))
( (S 
    (NP-SBJ (JJ Several) (NNS analysts) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (PRP they) )
          (VP (VBD expected) 
            (S 
              (NP-SBJ 
                (NP (NNP Warner-Lambert) (POS 's) )
                (NN profit) )
              (ADVP (RB also) )
              (VP (TO to) 
                (VP (VB increase) 
                  (PP-EXT (IN by) 
                    (NP 
                      (QP (JJR more) (IN than) (CD 20) )
                      (NN %) ))
                  (PP-DIR (IN from) 
                    (NP 
                      (NP 
                        (NP 
                          (QP ($ $) (CD 87.7) (CD million) )
                          (-NONE- *U*) )
                        (, ,) (CC or) 
                        (NP 
                          (NP ($ $) (CD 1.25) (-NONE- *U*) )
                          (NP-ADV (DT a) (NN share) ))
                        (, ,) )
                      (SBAR 
                        (WHNP-2 (-NONE- 0) )
                        (S 
                          (NP-SBJ (PRP it) )
                          (VP (VBD reported) 
                            (NP (-NONE- *T*-2) )
                            (PP-TMP (IN in) 
                              (NP 
                                (NP (DT the) (JJ like) (NN period) )
                                (NP-TMP (JJ last) (NN year) )))))))))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 (DT The) (NN company) )
    (VP (VBZ is) 
      (VP (VBN praised) 
        (NP (-NONE- *-1) )
        (PP (IN by) 
          (NP-LGS (NNS analysts) ))
        (PP-PRP (IN for) 
          (S-NOM 
            (NP-SBJ (-NONE- *-1) )
            (VP 
              (VP 
                (ADVP-MNR (RB sharply) )
                (VBG lowering) 
                (NP (PRP$ its) (NNS costs) )
                (PP-TMP (IN in) 
                  (NP (JJ recent) (NNS years) )))
              (CC and) 
              (VP (VBG shedding) 
                (NP 
                  (NP (JJ numerous) (NNS companies) )
                  (PP (IN with) 
                    (NP (JJ low) (NN profit) (NNS margins) )))))))))
    (. .) ))
( (S-1 
    (NP-SBJ 
      (NP (DT The) (NN company) (POS 's) )
      (JJ lean) (NN operation) )
    (PRN 
      (, ,)
      (S 
        (NP-SBJ (NNS analysts) )
        (VP (VBD said) 
          (SBAR (-NONE- 0) 
            (S (-NONE- *T*-1) ))))
      (, ,) )
    (VP (VBD allowed) 
      (S 
        (NP-SBJ 
          (NP (JJ sharp-rising) (NNS sales) )
          (PP (IN from) 
            (NP 
              (NP (PRP$ its) (NN cholesterol) (NN drug) )
              (, ,) 
              (NP (NNP Lopid) )
              (, ,) )))
        (VP (TO to) 
          (VP (VB power) 
            (NP (NNS earnings) (NN growth) )))))
    (. .) ))
( (S 
    (NP-SBJ-1 (NNP Lopid) (NNS sales) )
    (VP (VBP are) 
      (VP (VBN expected) 
        (S 
          (NP-SBJ (-NONE- *-1) )
          (VP (TO to) 
            (VP (VB be) 
              (NP-PRD 
                (QP (RB about) ($ $) (CD 300) (CD million) )
                (-NONE- *U*) )
              (NP-TMP (DT this) (NN year) )
              (, ,) 
              (ADVP (RB up) 
                (PP (IN from) 
                  (NP 
                    (QP ($ $) (CD 190) (CD million) )
                    (-NONE- *U*) )
                  (PP-TMP (IN in) 
                    (NP (CD 1988) )))))))))
    (. .) ))
( (S 
    (PP-LOC (IN In) 
      (NP 
        (NP (NNP Morris) (NNP Plains) )
        (, ,) 
        (NP (NNP N.J.) )
        (, ,) ))
    (NP-SBJ 
      (NP (DT a) (NN spokesman) )
      (PP (IN for) 
        (NP (DT the) (NN company) )))
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ 
            (NP (DT the) (NNS analysts) (POS ') )
            (NNS projections) )
          (VP (VBP are) (`` ``) 
            (PP-LOC-PRD (IN in) 
              (NP (DT the) (NN ballpark) ))))))
    (. .) ('' '') ))
( (S 
    (NP-SBJ-2 
      (NP (NNP Squibb) (POS 's) )
      (NN profit) )
    (, ,) 
    (S-ADV 
      (NP-SBJ-3 (-NONE- *-2) )
      (VP (VBN estimated) 
        (PP (IN by) 
          (NP-LGS (NNS analysts) ))
        (S 
          (NP-SBJ (-NONE- *-3) )
          (VP (TO to) 
            (VP (VB be) 
              (PP-LOC-PRD 
                (NP 
                  (QP (RB about) (CD 18) )
                  (NN %) )
                (IN above) 
                (NP 
                  (NP 
                    (NP (DT the) 
                      (QP ($ $) (CD 123) (CD million) )
                      (-NONE- *U*) )
                    (, ,) (CC or) 
                    (NP 
                      (NP ($ $) (CD 1.25) (-NONE- *U*) )
                      (NP-ADV (DT a) (NN share) )))
                  (, ,) 
                  (SBAR 
                    (WHNP-1 (-NONE- 0) )
                    (S 
                      (NP-SBJ (PRP it) )
                      (VP (VBD earned) 
                        (NP (-NONE- *T*-1) )
                        (PP-TMP (IN in) 
                          (NP 
                            (NP (DT the) (JJ third) (NN quarter) )
                            (PP (IN of) 
                              (NP (CD 1988) )))))))
                  (, ,) )))))))
    (VP (VBD was) 
      (NP-PRD 
        (NP (DT the) (NN result) )
        (PP (IN of) 
          (NP 
            (NP 
              (ADJP (RB especially) (JJ strong) )
              (NNS sales) )
            (PP (IN of) 
              (NP 
                (NP (PRP$ its) (NNP Capoten) (NN drug) )
                (PP (IN for) 
                  (S-NOM 
                    (NP-SBJ (-NONE- *) )
                    (VP (VBG treating) 
                      (NP 
                        (NP (JJ high) (NN blood) (NN pressure) )
                        (CC and) 
                        (NP (JJ other) (NN heart) (NN disease) )))))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 (DT The) (NN company) )
    (VP (VBD was) 
      (VP 
        (ADVP-MNR (RB officially) )
        (VBN merged) 
        (NP (-NONE- *-1) )
        (PP-CLR (IN with) 
          (NP (NNP Bristol-Myers) (NNP Co.) ))
        (NP-TMP (RBR earlier) (DT this) (NN month) )))
    (. .) ))
( (S 
    (NP-SBJ-1 (NNP Bristol-Myers) )
    (VP (VBD declined) 
      (S 
        (NP-SBJ (-NONE- *-1) )
        (VP (TO to) 
          (VP (VB comment) ))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Mr.) (NNP Riccardo) )
      (PP (IN of) 
        (NP (NNP Bear) (NNP Stearns) )))
    (VP (VBD said) 
      (SBAR (IN that) 
        (S 
          (NP-SBJ 
            (NP 
              (NP 
                (NP (NNP Schering-Plough) (NNP Corp.) (POS 's) )
                (JJ expected) (NN profit) (NN rise) )
              (PP (IN of) 
                (NP 
                  (QP (RB about) (CD 18) (NN %) (TO to) (CD 20) (NN %) )
                  (-NONE- *U*) )))
            (, ,) 
            (CC and)
            (NP 
              (NP 
                (NP (NNP Bristol-Meyers) (POS 's) )
                (JJ expected) (NN profit) (NN increase) )
              (PP (IN of) 
                (NP 
                  (QP (RB about) (CD 13) )
                  (NN %) ))))
          (VP (VBP are) 
            (SBAR-PRP-PRD 
              (ADVP (RB largely) )
              (IN because) (`` ``) 
              (S 
                (NP-SBJ-1 (DT those) (NNS companies) )
                (VP (VBP are) 
                  (ADVP (RB really) )
                  (VP (VBN managed) 
                    (NP (-NONE- *-1) )
                    (ADVP-MNR (RB well) )))))))))
    (. .) ('' '') ))
( (S 
    (NP-SBJ (NN ScheringPlough) )
    (VP (VBD earned) 
      (NP 
        (NP 
          (QP ($ $) (CD 94.4) (CD million) )
          (-NONE- *U*) )
        (, ,) (CC or) 
        (NP 
          (NP (CD 84) (NNS cents) )
          (NP-ADV (DT a) (NN share) )))
      (, ,) 
      (SBAR-ADV (IN while) 
        (S 
          (NP-SBJ (NNP Bristol-Myers) )
          (VP (VBD earned) 
            (NP 
              (NP 
                (QP ($ $) (CD 232.3) (CD million) )
                (-NONE- *U*) )
              (, ,) (CC or) 
              (NP 
                (NP (CD 81) (NNS cents) )
                (NP-ADV (DT a) (NN share) )))
            (, ,) 
            (PP-TMP (IN in) 
              (NP 
                (NP (DT the) (JJ like) (NN period) )
                (ADVP-TMP 
                  (NP (DT a) (NN year) )
                  (RBR earlier) )))))))
    (. .) ))
( (S 
    (PP-LOC (IN In) 
      (NP 
        (NP (NNP Madison) )
        (, ,) 
        (NP (NNP N.J.) )))
    (, ,) 
    (NP-SBJ 
      (NP (DT a) (NN spokesman) )
      (PP (IN for) 
        (NP (NNP Schering-Plough) )))
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (DT the) (NN company) )
          (VP (VBZ has) 
            (NP (`` ``) 
              (NP (DT no) (NNS problems) )
              ('' '') 
              (PP (IN with) 
                (NP 
                  (NP (DT the) (JJ average) (NN estimate) 
                    (SBAR (-NONE- *ICH*-1) ))
                  (PP (IN by) 
                    (NP (DT a) (NNS analysts) ))
                  (SBAR-1 (IN that) 
                    (S 
                      (NP-SBJ 
                        (NP (JJ third-quarter) (NNS earnings) )
                        (PP (IN per) 
                          (NP (NN share) )))
                      (VP (VBD rose) 
                        (PP-EXT (IN by) 
                          (NP 
                            (QP (RB about) (CD 19) )
                            (NN %) ))
                        (, ,) 
                        (PP-DIR (TO to) 
                          (NP ($ $) (CD 1) (-NONE- *U*) ))))))))))))
    (. .) ))
( (S 
    (S-TPC-2 
      (NP-SBJ-1 (DT The) (NN company) )
      (VP (VBZ expects) 
        (S 
          (NP-SBJ (-NONE- *-1) )
          (VP (TO to) 
            (VP (VB achieve) 
              (NP 
                (NP (DT the) 
                  (ADJP (CD 20) (NN %) )
                  (NN increase) )
                (PP-LOC (IN in) 
                  (NP (JJ full-year) (NNS earnings) ))
                (PP (IN per) 
                  (NP (NN share) )))
              (, ,) 
              (SBAR-ADV (IN as) 
                (S 
                  (NP-SBJ (PRP it) )
                  (VP (VBD projected) 
                    (PP (IN in) 
                      (NP (DT the) (NN spring) ))))))))))
    (, ,) 
    (NP-SBJ (DT the) (NN spokesman) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S 
    (ADVP-TMP (RB Meanwhile) )
    (, ,) 
    (NP-SBJ (NNS analysts) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ 
            (NP 
              (NP (NNP Pfizer) (POS 's) )
              (JJ recent) (NN string) )
            (PP (IN of) 
              (NP (JJ lackluster) (JJ quarterly) (NNS performances) )))
          (VP (VBD continued) 
            (, ,)
            (SBAR-ADV (IN as) 
              (S 
                (NP-SBJ-1 
                  (NP (NNS earnings) )
                  (PP-TMP (IN in) 
                    (NP (DT the) (NN quarter) )))
                (VP (VBD were) 
                  (VP (VBN expected) 
                    (S 
                      (NP-SBJ (-NONE- *-1) )
                      (VP (TO to) 
                        (VP (VB decline) 
                          (PP-EXT (IN by) 
                            (NP 
                              (QP (RB about) (CD 5) )
                              (NN %) )))))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Sales) )
      (PP (IN of) 
        (NP 
          (NP 
            (NP (NNP Pfizer) (POS 's) )
            (JJ important) (NNS drugs) )
          (, ,) 
          (NP 
            (NP 
              (NP (NNP Feldene) )
              (PP (IN for) 
                (S-NOM 
                  (NP-SBJ (-NONE- *) )
                  (VP (VBG treating) 
                    (NP (NN arthritis) )))))
            (, ,) 
            (CC and)
            (NP 
              (NP (NNP Procardia) )
              (, ,) 
              (NP (DT a) (NN heart) (NN medicine) )
              (, ,) )))))
    (VP (VBP have) 
      (VP (VBN shrunk) 
        (PP-PRP (RB because) (IN of) 
          (NP (JJ increased) (NN competition) ))))
    (. .) ))
( (S (`` ``) 
    (S-TPC-1 
      (NP-SBJ (DT The) 
        (PRN 
          (-LRB- -LRB-)
          (JJ strong) 
          (-RRB- -RRB-)
          )
        (NN dollar) )
      (VP (VBD hurt) 
        (NP (NNP Pfizer) )
        (NP-ADV (DT a) (NN lot) )
        (, ,) 
        (ADVP (RB too) )))
    (, ,) ('' '') 
    (NP-SBJ (NNP Mr.) (NNP Sweig) )
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (. .) ))
( (S 
    (PP-TMP (IN In) 
      (NP (DT the) (JJ third) (NN quarter) ))
    (NP-TMP (JJ last) (NN year) )
    (, ,) 
    (NP-SBJ (NNP Pfizer) )
    (VP (VBD earned) 
      (NP 
        (NP 
          (QP ($ $) (CD 216.8) (CD million) )
          (-NONE- *U*) )
        (, ,) (CC or) 
        (NP 
          (NP ($ $) (CD 1.29) (-NONE- *U*) )
          (NP-ADV (DT a) (NN share) ))))
    (. .) ))
( (S 
    (PP-LOC (IN In) 
      (NP (NNP New) (NNP York) ))
    (, ,) 
    (NP-SBJ (DT the) (NN company) )
    (VP (VBD declined) 
      (NP (NN comment) ))
    (. .) ))
( (S 
    (NP-SBJ (NNS Analysts) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (PRP they) )
          (VP (VBD expected) 
            (S 
              (NP-SBJ 
                (NP (NNP Upjohn) (POS 's) )
                (NN profit) )
              (VP (TO to) 
                (VP 
                  (VP (VB be) 
                    (ADJP-PRD (JJ flat) ))
                  (CC or) 
                  (VP (VB rise) 
                    (PP-EXT (IN by) 
                      (NP 
                        (NP 
                          (QP (RB only) (RB about) (CD 2) (NN %) (TO to) (CD 4) (NN %) )
                          (-NONE- *U*) )
                        (SBAR (IN as) 
                          (S 
                            (NP-SBJ-2 (-NONE- *) )
                            (VP (VBN compared) 
                              (NP (-NONE- *-2) )
                              (PP-CLR (IN with) 
                                (NP 
                                  (NP 
                                    (NP 
                                      (QP ($ $) (CD 89.6) (CD million) )
                                      (-NONE- *U*) )
                                    (, ,) (CC or) 
                                    (NP 
                                      (NP (CD 49) (NNS cents) )
                                      (NP-ADV (DT a) (NN share) )))
                                  (, ,) 
                                  (SBAR 
                                    (WHNP-1 (-NONE- 0) )
                                    (S 
                                      (NP-SBJ (PRP it) )
                                      (VP (VBD earned) 
                                        (NP (-NONE- *T*-1) )
                                        (ADVP-TMP 
                                          (NP (DT a) (NN year) )
                                          (RB ago) )))))))))))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Upjohn) (POS 's) )
      (JJ biggest-selling) (NNS drugs) )
    (VP (VBP are) 
      (NP-PRD 
        (NP 
          (NP (NNP Xanax) )
          (, ,) 
          (NP (DT a) (NN tranquilizer) ))
        (, ,) 
        (CC and)
        (NP 
          (NP (NNP Halcion) )
          (, ,) 
          (NP (DT a) (NN sedative) ))))
    (. .) ))
( (S 
    (NP-SBJ-1 
      (NP (NNS Sales) )
      (PP (IN of) 
        (NP (DT both) (NNS drugs) )))
    (VP (VBP have) 
      (VP (VBN been) 
        (VP (VBN hurt) 
          (NP (-NONE- *-1) )
          (PP (IN by) 
            (NP-LGS 
              (NP 
                (NP (JJ new) (NN state) (NNS laws) )
                (VP (VBG restricting) 
                  (NP 
                    (NP (DT the) (NNS prescriptions) )
                    (PP (IN of) 
                      (NP (JJ certain) (JJ tranquilizing) (NNS medicines) )))))
              (CC and) 
              (NP 
                (NP (JJ adverse) (NN publicity) )
                (PP (IN about) 
                  (NP 
                    (NP (DT the) (JJ excessive) (NN use) )
                    (PP (IN of) 
                      (NP (DT the) (NNS drugs) ))))))))))
    (. .) ))
( (S 
    (S-TPC-2 
      (ADVP (RB Also) )
      (, ,) 
      (S 
        (NP-SBJ 
          (NP 
            (NP (DT the) (NN company) (POS 's) )
            (JJ hair-growing) (NN drug) )
          (, ,) 
          (NP (NNP Rogaine) )
          (, ,) )
        (VP (VBZ is) 
          (VP (VBG selling) 
            (ADVP-MNR (RB well) )
            (: --) 
            (PP (IN at) 
              (NP 
                (NP 
                  (QP (RB about) ($ $) (CD 125) (CD million) )
                  (-NONE- *U*) )
                (PP (IN for) 
                  (NP (DT the) (NN year) )))))))
      (, ,) (CC but) 
      (S 
        (NP-SBJ-1 
          (NP 
            (NP (DT the) (NN company) (POS 's) )
            (NN profit) )
          (PP (IN from) 
            (NP (DT the) (NN drug) )))
        (VP (VBZ has) 
          (VP (VBN been) 
            (VP (VBN reduced) 
              (NP (-NONE- *-1) )
              (PP (IN by) 
                (NP-LGS 
                  (NP 
                    (NP (NNP Upjohn) (POS 's) )
                    (JJ expensive) (NN print) 
                    (CC and)
                    (NN television) (NNS campaigns) )
                  (PP (IN for) 
                    (NP (VBG advertising) )))))))))
    (, ,) 
    (NP-SBJ (NNS analysts) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S 
    (PP-LOC (IN In) 
      (NP 
        (NP (NNP Kalamazoo) )
        (, ,) 
        (NP (NNP Mich.) )
        (, ,) ))
    (NP-SBJ (NNP Upjohn) )
    (VP (VBD declined) 
      (NP (NN comment) ))
    (. .) ))
